Cenduit has acquired Patient Reminders, a service that allows clients/sponsors to reach patients directly with personalized messages and reminders about crucial aspects of their studies—increasing patient compliance and retention in clinical trials without purchasing special devices.

Cenduit clients now have the option to access a standalone product or utilize it as a component of their Interactive Response Technology (IRT) system. All IRT data can be integrated into the Patient Reminders platform to complete the package of patient participation, including arriving at appointments on time, taking medications on time, returning medications and drug accountability.

According to Cenduit, sites that can successfully engage patients through direct communication and reminders about crucial components of their studies will differentiate themselves in the industry and increase their probability of success. A recent study found a trial in which patients were reminded of appointments via text message saw a 40% increase in retention rates.

“We are excited about making our first acquisition—the first of many steps we are taking to create happier sites,” said Dr. Jogin Desai, CEO of Cenduit. “Happy sites are more productive and more profitable, and Cenduit sites are happier because we understand that technology is only part of the equation needed for their success. The other part is a thorough understanding and response to patient and sponsor needs through continually evolving innovative products and services. Acquiring Patient Reminders is one more example of how Cenduit enables site efficiency and patient compliance for superior outcomes in current and future trials.”

Mark Taggart, CEO of Patient Reminders, said it is a natural fit. “The technology we’ve developed simplifies and amplifies the effectiveness of patient communication throughout a clinical trial. It’s an honor to become part of the Cenduit portfolio.”